Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
KRM Ayurveda
Price Band
₹128.0–135.0
Issue Size
₹77.49 Cr
Lot Size
1,000 shares
Min Investment
₹270,000
GMP
+₹22.5 (16.67%)
Issue Price
₹135.0
calendar_month Important Dates
bar_chart Subscription Status
Subscription data unavailable
trending_up Grey Market Premium (GMP)
GMP
+₹22.5
GMP %
+16.67%
Est. Listing
₹157.5
schedule Updated: 14 Jul 2026 15:52
Share GMP:
business About the Company
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities: Beds, including general wards and premium rooms. Panchakarma treatment units. Herbal pharmacy and medicine preparation unit. Ayurvedic diet kitchen Consultation chambers for Vaidyas (Ayurvedic physicians). In-house yoga and meditation hall. Services: In-Patient & Out-Patient Care: Treatment for chronic diseases, lifestyle disorders, and post-operative rehabilitation. Panchakarma Therapies: Detoxification and rejuvenation programs. Specialized Clinics: Orthopedic care, skin and hair care, women’s wellness, geriatric care. Wellness Packages: Stress management, weight management, preventive health plans. Medicinal Sales: Dispensary of in-house and certified Ayurvedic medicines. Diet & Lifestyle Counseling: Personalized nutrition and yoga consultation As on December 31, 2025, the company have total of 443 employees operating under various departments. Competitive Strengths: Skilled Ayurvedic physicians and certified therapists ensuring treatment quality. Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy. Trusted brand with loyal customer base and repeat clientele.
payments Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
Key Ratios
EPS
₹7.79
NAV
₹1602.40
ROE
67.86%
ROCE
43.33%
RoNW
67.86%
P/B Value
0.08
P/E Ratio
17.32
Market Cap
₹287.02 Cr
PAT Margin
15.80%
Debt/Equity
1.31
Promoters
Puneet Dhawan and Tanya Dhawan
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Capital Expenditure for Construction and Development of Telemedicine Operational Facilities 13.67 2 Purchase of CRM Software and Hardware Infrastructure 1.42 3 Human Resources 5.44 4 Repayment/Prepayment of loan 12.50 5 Working Capital Requirement 22.90 6 General Corporate Purposes 10.00 7 Issue Expenses 11.57 Total 77.49
info Issue Details
pie_chart Investor Allocation
Registrar
Lead Managers / Book Running
timeline IPO Timeline
Open
21 Jan 2026
Close
23 Jan 2026
Allotment
27 Jan 2026
Listing
29 Jan 2026